Accelerating access to new veterinary trypanocides for Africa

dc.coverageAfrica
dc.creatorFAO; WOAH; AU;
dc.date2026-05-15T14:25:17Z
dc.date2026-05-15T14:25:17Z
dc.date2026
dc.date2026-05-15T14:19:55Z
dc.date.accessioned2026-06-28T00:09:50Z
dc.descriptionAfrican animal trypanosomosis (AAT) severely impacts livestock productivity, rural livelihoods and food security across sub-Saharan Africa. Current treatment options are outdated, increasingly ineffective and in some cases unsafe. The emergence and spread of drug resistance frequently compounds these problems. Recent international initiatives have revived efforts to develop innovative, modern, efficient and safe products to prevent and treat AAT. This brief advocates for urgent engagement in regulatory support and coordinated stakeholder action to introduce a new generation of safe, effective and sustainable veterinary trypanocides for African livestock systems, and for progress towards the development of vaccines.
dc.format3 p.
dc.formatapplication/pdf
dc.identifierhttps://openknowledge.fao.org/handle/20.500.14283/cd9735en
dc.identifier.urihttp://hdl.handle.net/123456789/301599
dc.languageEnglish
dc.publisherFAO ;
dc.rightsShared
dc.rightsCC BY 4.0
dc.titleAccelerating access to new veterinary trypanocides for Africa
dc.typePolicy brief

Archivos